Clinical Trial Update: Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 vaccine therapy in chronic myelogenous leukemia. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Vaccine therapy

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Leukemia | Phase 2 | Status: COMPLETED